labtestsonline更新疾病筛查监测的新指南

根据一项近期对医学权威的调查，在线实验室检验(www.labtestsonline.org)升级更新了该网站对筛查监测的建议。

新建议充分考虑了对筛查频率的不同观点，提供一位或者两位公认权威的意见，阐明他们认可或者不认可的意见。例如，对50多岁的成年人，网站提供详细的前列腺癌筛查监测建议，包括美国癌症学会、美国预防医学学院、美国泌尿病学会、美国国立癌症网络的相同与不同观点的细微之处。

关于前列腺筛查监测，对如何解释前列腺特异抗原检查结果、何时采用激进治疗方法或者仅仅采用密切观察病情变化，都有着不同的观点。癌症将仅仅缓慢生长或者是否危及生命的不确定性，许多治疗措施的严重副作用，导致了许多争论并进一步进行前列腺特异抗原检查。这些情况都显示了患者知情以及与他们的医生讨论病情以指导治疗的重要性。

关于新筛查监测的信息来自一项规模复杂的调查结果，调查涵盖了60多个政府机构、医学学会、倡议与支持团体以及其它机构的文献报道。

New Screening Guidelines from Lab Tests Online
 
Based on a recent survey of leading medical authorities, Lab Tests Online (www.labtestsonline.org) has updated the site’s screening recommendations.

The new recommendations take into consideration differing opinions on how frequently screening tests should be performed by providing the view of one or two more-acknowledged authorities, clarifying the ways they agree and disagree. For example, for adults over the age of 50, the site offers details on screening recommendations for prostate cancer, including subtle common positions and differences of opinion among the American Cancer Society, the American College of Preventive Medicine, the American Urological Society, and the U.S. National Comprehensive Cancer Network.

In the case of prostate cancer screening, there are varying perspectives on how to interpret prostate-specific antigen (PSA) test results, and on when radical treatment or just watchful waiting is appropriate. Uncertainties about which cancers will be slow growing and which will be life threatening, combined with serious side effects of many treatments, have generated debate and prompted further research on PSA testing. The evidence highlights the need for patients to be informed and to have ongoing discussions with their doctors about their risk factors to help guide their care.

The information for the new screening pages is drawn from a comprehensive survey of current literature from more than 60 government agencies, medical societies, advocacy and support groups, and other organizations.